Cronos Stock Trades in Green After Signing Supply Deal with MediPharm

Cronos stock

Cronos Group (TSX:CRON) (NASDAQ:CRON) said Thursday that it has extended its cooperation with MediPharm Labs (TSX:LABS) (OTCQX:MEDIF). The two cannabis companies have disclosed a new supply deal. We don’t know the financial details yet, but the cooperation is being well received. At least, today it is, with Cronos stock currently trading in the green.

Here’s what we know.

Cronos Stock: The Latest and Greatest

Cronos Group and MediPharm Labs have an existing relationship, with MediPharm signing a contract in May with CRON, agreeing to supply it with bulk resin and cannabis concentrates. And this ...

Read The Full Article On PotStockNews.com

Get the latest marijuana stock news, cannabis on stock news on PotStockNews

All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.